SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 117.38 |
| Enterprise Value ($M) | 55.61 |
| Book Value ($M) | 278.77 |
| Book Value / Share | 3.94 |
| Price / Book | 0.42 |
| NCAV ($M) | 267.08 |
| NCAV / Share | 3.78 |
| Price / NCAV | 0.44 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.53 |
| Return on Assets (ROA) | -0.55 |
| Return on Equity (ROE) | -0.63 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 23.52 |
| Current Ratio | 23.52 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 289.41 |
| Assets | 301.10 |
| Liabilities | 22.33 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Bank Of America Corp /de/ | |||
| 13G/A | Flynn James E | |||
| 13G | Sio Capital Management, LLC | |||
| 13G | Point72 Asset Management, L.P. | |||
| 13G/A | Cormorant Asset Management, LP | 0.00 | -100.00 | |
| 13G/A | Vanguard Group Inc | 4.90 | 0.00 | |
| 13D/A | NSV Investments I, L.P. | 10.10 | -15.84 | |
| 13G/A | Citadel Advisors Llc | 7.30 | ||
| 13G | BlackRock, Inc. | 6.50 | ||
| 13G | Tang Capital Partners Lp | 5.20 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 176,266 | 590,102 | 29.87 | |
| 199,459 | 659,804 | 30.23 | |
| 289,777 | 1,107,737 | 26.16 | |
| 313,520 | 1,527,376 | 20.53 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| VOR – Vor Biopharma Inc. | VRTX – Vertex Pharmaceuticals Incorporated |
| VTRS – Viatris Inc. | VYGR – Voyager Therapeutics, Inc. |
| XBIT – XBiotech Inc. |
Financial data and stock pages provided by
Fintel.io